
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg, Nicholas P. Restifo
Science (2015) Vol. 348, Iss. 6230, pp. 62-68
Open Access | Times Cited: 2200
Steven A. Rosenberg, Nicholas P. Restifo
Science (2015) Vol. 348, Iss. 6230, pp. 62-68
Open Access | Times Cited: 2200
Showing 1-25 of 2200 citing articles:
CAR T cell immunotherapy for human cancer
Carl H. June, Roddy S. O’Connor, Omkar U. Kawalekar, et al.
Science (2018) Vol. 359, Iss. 6382, pp. 1361-1365
Closed Access | Times Cited: 2434
Carl H. June, Roddy S. O’Connor, Omkar U. Kawalekar, et al.
Science (2018) Vol. 359, Iss. 6382, pp. 1361-1365
Closed Access | Times Cited: 2434
Delivery technologies for cancer immunotherapy
Rachel Riley, Carl H. June, Róbert Langer, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 175-196
Open Access | Times Cited: 2129
Rachel Riley, Carl H. June, Róbert Langer, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 175-196
Open Access | Times Cited: 2129
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang, Zemin Zhang
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 8, pp. 807-821
Open Access | Times Cited: 2019
Yuanyuan Zhang, Zemin Zhang
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 8, pp. 807-821
Open Access | Times Cited: 2019
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
Sattva S. Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Nature Reviews Clinical Oncology (2017) Vol. 15, Iss. 1, pp. 47-62
Open Access | Times Cited: 2013
Sattva S. Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Nature Reviews Clinical Oncology (2017) Vol. 15, Iss. 1, pp. 47-62
Open Access | Times Cited: 2013
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce, Douglas T. Fearon
Science (2015) Vol. 348, Iss. 6230, pp. 74-80
Open Access | Times Cited: 1993
Johanna A. Joyce, Douglas T. Fearon
Science (2015) Vol. 348, Iss. 6230, pp. 74-80
Open Access | Times Cited: 1993
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1426
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1426
Immunotherapy in colorectal cancer: rationale, challenges and potential
Karuna Ganesh, Zsofia K. Stadler, Andrea Cercek, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 6, pp. 361-375
Open Access | Times Cited: 1396
Karuna Ganesh, Zsofia K. Stadler, Andrea Cercek, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 6, pp. 361-375
Open Access | Times Cited: 1396
Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
Imran Siddiqui, Karin Schaeuble, Vijaykumar Chennupati, et al.
Immunity (2019) Vol. 50, Iss. 1, pp. 195-211.e10
Open Access | Times Cited: 1245
Imran Siddiqui, Karin Schaeuble, Vijaykumar Chennupati, et al.
Immunity (2019) Vol. 50, Iss. 1, pp. 195-211.e10
Open Access | Times Cited: 1245
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger, Daisy Dai, Brendan Horton, et al.
Cancer Cell (2017) Vol. 31, Iss. 5, pp. 711-723.e4
Open Access | Times Cited: 1188
Stefani Spranger, Daisy Dai, Brendan Horton, et al.
Cancer Cell (2017) Vol. 31, Iss. 5, pp. 711-723.e4
Open Access | Times Cited: 1188
Defining ‘T cell exhaustion’
Christian U. Blank, W. Nicholas Haining, Werner Held, et al.
Nature reviews. Immunology (2019) Vol. 19, Iss. 11, pp. 665-674
Open Access | Times Cited: 1178
Christian U. Blank, W. Nicholas Haining, Werner Held, et al.
Nature reviews. Immunology (2019) Vol. 19, Iss. 11, pp. 665-674
Open Access | Times Cited: 1178
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni, Étienne Becht, Michael Fehlings, et al.
Nature (2018) Vol. 557, Iss. 7706, pp. 575-579
Closed Access | Times Cited: 1134
Yannick Simoni, Étienne Becht, Michael Fehlings, et al.
Nature (2018) Vol. 557, Iss. 7706, pp. 575-579
Closed Access | Times Cited: 1134
CD8+ T cell states in human cancer: insights from single-cell analysis
Anne M. van der Leun, Daniela S. Thommen, Ton N. Schumacher
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 218-232
Open Access | Times Cited: 1120
Anne M. van der Leun, Daniela S. Thommen, Ton N. Schumacher
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 218-232
Open Access | Times Cited: 1120
Gene therapy returns to centre stage
Luigi Naldini
Nature (2015) Vol. 526, Iss. 7573, pp. 351-360
Closed Access | Times Cited: 1050
Luigi Naldini
Nature (2015) Vol. 526, Iss. 7573, pp. 351-360
Closed Access | Times Cited: 1050
Advances in immunotherapy for hepatocellular carcinoma
Bruno Sangro, Pablo Sarobe, Sandra Hervás‐Stubbs, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 8, pp. 525-543
Open Access | Times Cited: 938
Bruno Sangro, Pablo Sarobe, Sandra Hervás‐Stubbs, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 8, pp. 525-543
Open Access | Times Cited: 938
Targeting PI3K/Akt signal transduction for cancer therapy
Yan He, Miao Sun, Guo Geng Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 915
Yan He, Miao Sun, Guo Geng Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 915
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu, Patrick A. Ott, Catherine J. Wu
Nature reviews. Immunology (2017) Vol. 18, Iss. 3, pp. 168-182
Open Access | Times Cited: 897
Zhuting Hu, Patrick A. Ott, Catherine J. Wu
Nature reviews. Immunology (2017) Vol. 18, Iss. 3, pp. 168-182
Open Access | Times Cited: 897
The immunology of hepatocellular carcinoma
Marc Ringelhan, Dominik Pfister, Tracy O’Connor, et al.
Nature Immunology (2018) Vol. 19, Iss. 3, pp. 222-232
Closed Access | Times Cited: 860
Marc Ringelhan, Dominik Pfister, Tracy O’Connor, et al.
Nature Immunology (2018) Vol. 19, Iss. 3, pp. 222-232
Closed Access | Times Cited: 860
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Krijn K. Dijkstra, Chiara M. Cattaneo, Fleur Weeber, et al.
Cell (2018) Vol. 174, Iss. 6, pp. 1586-1598.e12
Open Access | Times Cited: 837
Krijn K. Dijkstra, Chiara M. Cattaneo, Fleur Weeber, et al.
Cell (2018) Vol. 174, Iss. 6, pp. 1586-1598.e12
Open Access | Times Cited: 837
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Wei Yang, Yibing Bai, Ying Xiong, et al.
Nature (2016) Vol. 531, Iss. 7596, pp. 651-655
Open Access | Times Cited: 804
Wei Yang, Yibing Bai, Ying Xiong, et al.
Nature (2016) Vol. 531, Iss. 7596, pp. 651-655
Open Access | Times Cited: 804
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros, Maria R. Parkhurst, Eric Tran, et al.
Nature Medicine (2016) Vol. 22, Iss. 4, pp. 433-438
Open Access | Times Cited: 791
Alena Gros, Maria R. Parkhurst, Eric Tran, et al.
Nature Medicine (2016) Vol. 22, Iss. 4, pp. 433-438
Open Access | Times Cited: 791
A STING-activating nanovaccine for cancer immunotherapy
Min Luo, Hua Wang, Zhaohui Wang, et al.
Nature Nanotechnology (2017) Vol. 12, Iss. 7, pp. 648-654
Open Access | Times Cited: 769
Min Luo, Hua Wang, Zhaohui Wang, et al.
Nature Nanotechnology (2017) Vol. 12, Iss. 7, pp. 648-654
Open Access | Times Cited: 769
In vitro and ex vivo strategies for intracellular delivery
Martin P. Stewart, Armon Sharei, Xiaoyun Ding, et al.
Nature (2016) Vol. 538, Iss. 7624, pp. 183-192
Closed Access | Times Cited: 766
Martin P. Stewart, Armon Sharei, Xiaoyun Ding, et al.
Nature (2016) Vol. 538, Iss. 7624, pp. 183-192
Closed Access | Times Cited: 766
Current Challenges in Cancer Treatment
Jon Zugazagoitia, Cristiano Guedes, Santiago Ponce, et al.
Clinical Therapeutics (2016) Vol. 38, Iss. 7, pp. 1551-1566
Open Access | Times Cited: 756
Jon Zugazagoitia, Cristiano Guedes, Santiago Ponce, et al.
Clinical Therapeutics (2016) Vol. 38, Iss. 7, pp. 1551-1566
Open Access | Times Cited: 756
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L. Roth, Cristina Puig-Saus, Ruby Yu, et al.
Nature (2018) Vol. 559, Iss. 7714, pp. 405-409
Open Access | Times Cited: 713
Theodore L. Roth, Cristina Puig-Saus, Ruby Yu, et al.
Nature (2018) Vol. 559, Iss. 7714, pp. 405-409
Open Access | Times Cited: 713
Immunogenicity of somatic mutations in human gastrointestinal cancers
Eric Tran, Mojgan Ahmadzadeh, Yong‐Chen Lu, et al.
Science (2015) Vol. 350, Iss. 6266, pp. 1387-1390
Open Access | Times Cited: 672
Eric Tran, Mojgan Ahmadzadeh, Yong‐Chen Lu, et al.
Science (2015) Vol. 350, Iss. 6266, pp. 1387-1390
Open Access | Times Cited: 672